HCA Healthcare Named a World's Most Admired Company by Fortune for the 12th Consecutive Year
MWN-AI** Summary
HCA Healthcare, Inc. (NYSE: HCA), one of the United States' foremost healthcare providers, has earned a distinguished place on Fortune’s 2026 World’s Most Admired Companies list, marking the twelfth consecutive year it has achieved this accolade. This year, HCA secured the top position in its industry, underscoring its commitment to excellence in healthcare.
CEO Sam Hazen expressed pride in this recognition, attributing the honor to the organization’s dedicated colleagues who exemplify compassion and high standards in patient care. The recognition comes from a comprehensive analysis by Fortune and Korn Ferry, which scrutinized 685 companies across diverse industries worldwide. Companies were evaluated based on nine critical criteria, including innovation, management quality, financial stability, and social responsibility.
HCA Healthcare is focused on advancing healthcare delivery through research and innovation. With the expansion of the HCA Healthcare Research Institute, the company has bolstered its clinical research efforts, encompassing 54 sites and over 520 active studies, thus enriching patient care with valuable data. Moreover, its Digital Transformation & Innovation department is enhancing patient outcomes through advanced technology investments.
In supporting its workforce, HCA continues to offer substantial educational resources, investing over $40 million in tuition assistance for more than 11,700 staff members in the past year. Approximately 24% of these colleagues are pursuing nursing degrees. Additionally, HCA’s Leadership Institute fosters future leaders, equipping them with essential skills to navigate the healthcare landscape, resulting in over 40,140 graduates since inception.
As a prominent entity with 190 hospitals and around 2,500 care facilities across 19 states and the UK, HCA Healthcare remains committed to utilizing its extensive patient interactions to advance medical science and enhance care quality, establishing itself as a cornerstone of the healthcare industry.
MWN-AI** Analysis
HCA Healthcare’s recognition as one of Fortune's World’s Most Admired Companies for the 12th consecutive year underscores its strong brand reputation and continued commitment to excellence in patient care. Investors should view this accolade as a testament to HCA's robust operational performance and strategic focus on innovation and employee development, particularly in a challenging healthcare landscape.
The company's multi-faceted approach, encompassing advancements in research, technology investments, and an emphasis on personnel development, positions it strongly within the competitive healthcare sector. With 54 research sites and over 6,600 patients enrolled in clinical trials in 2025, HCA is not only enhancing patient outcomes but also contributing to the broader scientific community. This commitment to research and innovation can lead to long-term competitive advantages, making HCA a potentially attractive investment for those seeking exposure to the healthcare industry.
Additionally, HCA's substantial investment in employee education and leadership training reflects its recognition of the critical role that human capital plays in delivering high-quality healthcare. The Leadership Institute’s output of over 40,000 graduates positions HCA to sustain its operational excellence by fostering a skilled workforce capable of navigating the complexities of modern healthcare.
However, investors should remain cognizant of potential risks, including regulatory changes and shifts in reimbursement models that could impact profitability. Analyzing HCA's financial soundness, long-term investment, and social responsibility metrics from the Fortune survey provides further reassurance of its stability and growth potential.
In conclusion, HCA Healthcare's industry-leading innovations, commitment to quality care, and valuable organizational culture make it a compelling option for investors aiming to capitalize on trends within the healthcare sector. As the landscape evolves, HCA's strong foundation and forward-thinking strategies should maintain its competitive edge, potentially leading to sustained growth and shareholder value.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has been named on Fortune’s 2026 World’s Most Admired Companies list. HCA Healthcare is ranked No. 1 in its industry again this year.
“We are proud to again be recognized on Fortune’s World’s Most Admired Companies list,” said Sam Hazen, CEO of HCA Healthcare. “I am grateful to our colleagues for the way they lead with compassion and the high standards they set across the organization as we work to improve outcomes and experiences for patients.”
Since 1997, Fortune has collaborated with Korn Ferry to determine the World’s Most Admired Companies list. This year 685 companies across 51 industries and 29 countries were analyzed. The top-rated companies were rated by executives, directors and analysts on nine criteria: innovation, people management, use of corporate assets, social responsibility, quality of management, financial soundness, long-term investment, quality of products and services, and global competitiveness.
HCA Healthcare strives to elevate the delivery of care through research and innovation. In 2025, HCA Healthcare Research Institute, the multispecialty clinical research arm of the company, grew to 54 sites across the country and enrolled more than 6,600 patients in more than 520 active research studies. HCA Healthcare’s Digital Transformation & Innovation department also continues to build upon technology platform investments to help improve patient outcomes, increase efficiency, strengthen the connection of the company’s care networks and create more time for what matters most: caring for patients.
HCA Healthcare also supports its colleagues and their continued education through its tuition assistance program that provided more than $40 million to more than 11,700 colleagues last year, with 24% of colleagues using their tuition assistance towards pursuing a nursing degree. With a strategic focus on skill-building and hands-on learning opportunities, HCA Healthcare is deeply committed to the continuous professional development of nursing staff through targeted educational experiences. The company also invests in its future leaders through the HCA Healthcare Leadership Institute, which provides leaders with the essential skills to lead teams, overcome business challenges and deliver value to patients and communities. Since inception, the Leadership Institute has graduated more than 40,140 colleagues from its programs, including more than 9,200 in 2025.
About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 190 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 19 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 44 million annual patient encounters to advance science, improve patient care and save lives.
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc. and its affiliates.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260226230094/en/
INVESTOR CONTACT:
Frank Morgan
615-344-2688
MEDIA CONTACT:
Harlow Sumerford
615-344-1851
FAQ**
How does being named on Fortune’s 2026 World’s Most Admired Companies list impact HCA Healthcare Inc. HCA's market position and investor perception in the highly competitive healthcare industry?
Given HCA Healthcare Inc. HCA's focus on research and innovation, what specific advancements have been made in patient care as a result of its clinical research initiatives?
How does HCA Healthcare Inc. HCA's tuition assistance program for colleagues reflect its long-term strategy for workforce development and patient care quality?
What are the implications of HCA Healthcare Inc. HCA's growth—a network of 190 hospitals and 2,500 ambulatory sites—on its financial stability and investment potential in the current healthcare market?
**MWN-AI FAQ is based on asking OpenAI questions about HCA Healthcare Inc. (NYSE: HCA).
NASDAQ: HCA
HCA Trading
0.22% G/L:
$536.885 Last:
362,031 Volume:
$535.78 Open:
